SRNE Sorrento Therapeutics, Inc. Stock Quote

Your browser is no longer supported. Please, upgrade your browser.

publish chart | save to portfolio | create alert

SRNE [NASD]

Sorrento Therapeutics, Inc.

Healthcare | Biotechnology | USA

statements

Index	-	P/E	-	EPS (ttm)	-1.61	Insider Own	34.21%	Shs Outstand	216.96M	Perf Week	61.66%
Market Cap	3.29B	Forward P/E	65.55	EPS next Y	0.22	Insider Trans	0.05%	Shs Float	200.97M	Perf Month	86.06%
Income	-270.20M	PEG	-	EPS next Q	-0.16	Inst Own	15.00%	Short Float	24.09%	Perf Quarter	454.62%
Sales	35.50M	P/S	92.79	EPS this Y	-14.80%	Inst Trans	5.82%	Short Ratio	1.09	Perf Half Y	388.81%
Book/sh	0.63	P/B	22.89	EPS next Y	126.50%	ROA	-49.40%	Target Price	25.00	Perf Year	555.45%
Cash/sh	-	P/C	-	EPS next 5Y	37.00%	ROE	-297.90%	52W Range	1.39 - 14.55	Perf YTD	326.63%
Dividend	-	P/FCF	-	EPS past 5Y	-11.10%	ROI	-91.30%	52W High	-0.89%	Beta	3.17
Dividend %	-	Quick Ratio	0.60	Sales past 5Y	52.40%	Gross Margin	68.10%	52W Low	937.41%	ATR	1.18
Employees	310	Current Ratio	0.60	Sales Q/Q	38.50%	Oper. Margin	-	RSI (14)	83.86	Volatility	16.14% 12.07%
Optionable	Yes	Debt/Eq	1.21	EPS Q/Q	22.60%	Profit Margin	-	Rel Volume	1.39	Prev Close	13.61
Shortable	Yes	LT Debt/Eq	1.07	Earnings	-	Payout	-	Avg Volume	44.50M	Price	14.42
Recom	2.00	SMA20	65.41%	SMA50	113.81%	SMA200	277.67%	Volume	62,006,795	Change	5.95%

Jul-31-20

Reiterated

H.C. Wainwright

Buy

$24 → $30

May-26-20

Initiated

Dawson James

Buy

$24

Oct-07-19

Initiated

JMP Securities

Mkt Outperform

$21

Jun-28-18

Initiated

B. Riley FBR, Inc.

Buy

$14.25

Jan-16-18

Reiterated

H.C. Wainwright

Buy

$20 → $30

May-22-17

Reiterated

Rodman & Renshaw

Buy

$30 → $20

May-22-17

Reiterated

FBR & Co.

Outperform

$13 → $9

Oct-03-16

Initiated

ROTH Capital

Buy

Apr-06-16

Reiterated

FBR Capital

Outperform

$21 → $16

Mar-16-16

Reiterated

FBR Capital

Outperform

$22 → $21

Dec-22-15

Initiated

FBR Capital

Outperform

$22

Dec-07-15

Resumed

Rodman & Renshaw

Buy

$45

Aug-03-15

Resumed

MLV & Co

Buy

$34

Jul-29-15

Reiterated

Brean Capital

Buy

$17 → $26

May-28-15

Initiated

Brean Capital

Buy

$17

Mar-17-15

Reiterated

H.C. Wainwright

Buy

$13 → $20

Oct-02-14

Initiated

H.C. Wainwright

Buy

$11

Jun-19-14

Initiated

MLV & Co

Buy

Dec-03-13

Initiated

Aegis Capital

Buy

$40

Nov-21-13

Initiated

CRT Capital

Buy

$11

Aug-07-20 02:01PM	XpresSpa Shares Are Facing More Problems InvestorPlace +5.95%
12:30PM	Will Sorrento Therapeutics (SRNE) Report Negative Q2 Earnings? What You Should Know Zacks
10:35AM	Unusual Options Activity Insight: Sorrento Therapeutics Benzinga
06:16AM	The Next Bull Run Will Be Harder For Sorrento Therapeutics InvestorPlace
Aug-05-20 10:57AM	Clueless investors just keep driving this stupidly bullish stock market higher, CNBCs Jim Cramer says MarketWatch +7.36%
07:13AM	Jim Cramer: Buyers, It's Time to Look in the Mirror TheStreet.com
Aug-04-20 06:28PM	Why Sorrento Therapeutics Stock Soared Today Motley Fool +31.42%
12:20PM	If You Own Sorrento Therapeutics (SRNE) Stock, Should You Sell It Now? Insider Monkey
Aug-03-20 05:18PM	Sorrentos New COVID-19 Test Could Be a Game Changer, Says 5-Star Analyst TipRanks +9.53%
Jul-31-20 05:52PM	Why Sorrento Therapeutics Stock Jumped Today Motley Fool
Jul-29-20 10:34AM	Sorrento (SRNE) to Report Q2 Earnings: What's in the Cards? Zacks
08:01AM	Sorrento Therapeutics Licenses 30-Minute Spit Test for Covid-19 Barrons.com
Jul-27-20 01:11PM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Sorrento Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 27, 2020 - SRNE Newsfile +6.86%
11:40AM	DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Sorrento Therapeutics, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm ACCESSWIRE
11:39AM	Why Sorrento Therapeutics Stock Is Jumping Today Motley Fool
11:30AM	Is Sorrento Therapeutics (SRNE) Outperforming Other Medical Stocks This Year? Zacks
10:50AM	The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of SRNE, CEMI and JCOM ACCESSWIRE
10:16AM	DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Sorrento Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
06:20AM	CLASS ACTION UPDATE for SRNE, CLNY and ERII: Levi and Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
Jul-26-20 09:45AM	Sorrento To Buy SmartPharm For Potential Covid-19 Treatment; Top Analyst Says Buy TipRanks
Jul-25-20 02:36PM	MONDAY DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Sorrento Therapeutics, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm ACCESSWIRE
Jul-24-20 08:44PM	Upcoming Phase 2 COVID-19 Trial Marks Key Milestone for Sorrento (SRNE); Analyst Says Buy TipRanks -6.54%
04:33PM	Sorrento Therapeutics to Buy Its Coronavirus Vaccine Development Partner Motley Fool
03:46PM	Why Sorrento Therapeutics Stock Slipped Today Motley Fool
12:59PM	SRNE Upcoming Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Sorrento Therapeutics, Inc Shareholders With Losses Exceeding $250K of Class Action and Lead Plaintiff Deadline: July 27, 2020 ACCESSWIRE
11:10AM	The Gross Law Firm Announces Class Actions on Behalf of Shareholders of SRNE, CLNY and CCL ACCESSWIRE
10:20AM	MONDAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Sorrento Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
09:00AM	Sorrento Enters Into Letter Of Intent To Acquire SmartPharm And Develop Pipeline Of Gene-Encoded Therapeutic Antibodies, Starting With Neutralizing Antibodies To Treat COVID-19 and Cancer Therapeutics PR Newswire
07:02AM	Better Coronavirus Stock: Sorrento Therapeutics vs. Vaxart Motley Fool
06:46AM	Sorrento Therapeutics May Be Ready For a Pullback InvestorPlace
Jul-23-20 05:50PM	The Gross Law Firm Announces Class Actions on Behalf of Shareholders of TUFN, SRNE and BKD ACCESSWIRE
04:50PM	4-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Sorrento Therapeutics, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm ACCESSWIRE
01:30PM	The Gross Law Firm Announces Class Actions on Behalf of Shareholders of NSP, SRNE and ERII ACCESSWIRE
11:40AM	LAWSUITS FILED AGAINST SRNE, KL and WRCDF - JAKUBOWITZ LAW PURSUES SHAREHOLDERS CLAIMS ACCESSWIRE
08:35AM	Earnings Estimates Moving Higher for Sorrento Therapeutics (SRNE): Time to Buy? Zacks
Jul-22-20 08:05PM	CLASS ACTION UPDATE for TUFN, SRNE and CLNY: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
07:00PM	DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Sorrento Therapeutics, Inc. and Encourages Investors to Contact the Firm Business Wire
06:12PM	SRNE ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of July 27, 2020 in the Class Action Filed on Behalf of Sorrento Therapeutics, Inc. Limited Shareholders Newsfile
04:45PM	5-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Sorrento Therapeutics, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm ACCESSWIRE
02:28PM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Sorrento Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 27, 2020 - SRNE Newsfile
01:00PM	SRNE Upcoming Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Sorrento Therapeutics, Inc Shareholders With Losses Exceeding $250K of Class Action and Lead Plaintiff Deadline: July 27, 2020 Newsfile
11:10AM	The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of SRNE, WFC and JCOM ACCESSWIRE
10:10AM	DEADLINE MONDAY REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Sorrento Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
Jul-21-20 11:15AM	LAWSUITS FILED AGAINST SRNE, CCL and KL - JAKUBOWITZ LAW PURSUES SHAREHOLDERS CLAIMS ACCESSWIRE
10:09AM	Sorrento Therapeutics gets FDA approval for COVID-19 drug trial Yahoo Finance Video
10:05AM	DEADLINE MONDAY ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Sorrento Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
08:06AM	Sorrento Therapeutics Has Made a Large Base Formation - Timing Is Key TheStreet.com
06:20AM	CLASS ACTION UPDATE for SRNE, WFC and IDEX: Levi and Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
Jul-20-20 11:40PM	FINAL DEADLINE IMMINENT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Sorrento Therapeutics, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm ACCESSWIRE +19.94%
07:25PM	Why Sorrento Therapeutics Stock Surged Today Motley Fool
03:21PM	Sorrento Shares Climb on FDA Covid-Drug Trial Clearance TheStreet.com
11:50AM	LAWSUITS FILED AGAINST R, SRNE and CLNY - JAKUBOWITZ LAW PURSUES SHAREHOLDERS CLAIMS ACCESSWIRE
10:58AM	SRNE Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Sorrento Therapeutics, Inc Shareholders With Losses Exceeding $250K of Class Action and Lead Plaintiff Deadline: July 27, 2020 ACCESSWIRE
10:04AM	7-DAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Sorrento Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
09:00AM	FDA clears Abivertinib for Phase 2 safety and efficacy study in hospitalized patients with moderate to severe COVID-19 PR Newswire
08:43AM	Implied Volatility Surging for Sorrento Therapeutics (SRNE) Stock Options Zacks
08:35AM	SHAREHOLDER ALERT: SRNE FSCT JCOM: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
07:30AM	SHAREHOLDER ALERT: SRNE CODX IDEX: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
06:20AM	SHAREHOLDER ALERT: SRNE IDEX GEO: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
Jul-18-20 06:52PM	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Sorrento Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline SRNE GlobeNewswire
Jul-17-20 01:30PM	CLASS ACTION UPDATE for CTMX, SRNE and BAYRY: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
12:30PM	IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Sorrento Therapeutics, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm ACCESSWIRE
12:20PM	The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of SRNE, CLNY and JCOM ACCESSWIRE
11:43AM	Sorrento Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Sorrento Therapeutics, Inc. To Contact The Firm Newsfile
06:49AM	Better Coronavirus Stock: Inovio vs. Sorrento Therapeutics Motley Fool
Jul-16-20 05:45PM	Sorrento Therapeutics (SRNE) Gains As Market Dips: What You Should Know Zacks
02:00PM	The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of SRNE, IDEX and KL ACCESSWIRE
01:33PM	SRNE Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action Against Sorrento Therapeutics, Inc and Encourages Investors With Losses Exceeding $250K to Contact the Firm ACCESSWIRE
12:10PM	The Gross Law Firm Announces Class Actions on Behalf of Shareholders of CTMX, SRNE and BKD ACCESSWIRE
11:30AM	The Gross Law Firm Announces Class Actions on Behalf of Shareholders of CTMX, SRNE and IDEX ACCESSWIRE
09:45AM	Scott+Scott Attorneys at Law LLP Reminds Investors of Securities Class Actions Against Sorrento Therapeutics, Inc. (SRNE) and July 27 Deadline GlobeNewswire
Jul-15-20 08:30PM	Lawsuits Filed Against SRNE, WFC and JCOM - Jakubowitz Law Pursues Shareholders Claims ACCESSWIRE -17.13%
07:10PM	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Sorrento Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - SRNE ACCESSWIRE
03:30PM	CLASS ACTION UPDATE for SRNE, CLNY and WFC: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
03:00PM	Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Colony Capital, Sorrento Therapeutics, Carnival Corporation, and Wells Fargo and Encourages Investors to Contact the Firm GlobeNewswire
Jul-14-20 06:20AM	SHAREHOLDER ALERT: PRA SRNE FSCT: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
Jul-13-20 11:01PM	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Sorrento Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - SRNE PR Newswire
01:35PM	The Gross Law Firm Announces Class Actions on Behalf of Shareholders of R, SRNE and WFC ACCESSWIRE
01:00PM	SRNE Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action Against Sorrento Therapeutics, Inc and Encourages Investors With Losses Exceeding $250K to Contact the Firm GlobeNewswire
09:31AM	Thinking about trading options or stock in Sorrento Therapeutics, Netflix, United Airlines, Royal Caribbean Cruises, or Plug Power? PR Newswire
01:30AM	The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of SRNE, CODX and GEO ACCESSWIRE
Jul-10-20 11:33PM	Sorrento Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Sorrento Therapeutics, Inc. To Contact The Firm Newsfile
Jul-09-20 07:15PM	SHAREHOLDER ALERT: SRNE CEMI MYL: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE +6.31%
07:12PM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Sorrento Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 27, 2020 - SRNE Newsfile
04:44PM	Shareholder Alert: Robbins LLP Announces It Is Investigating Sorrento Therapeutics, Inc. (SRNE) for Misleading Shareholders Business Wire
04:20PM	Lawsuits Filed Against CONN, CTMX and SRNE - Jakubowitz Law Pursues Shareholders Claims ACCESSWIRE
03:54PM	SORRENTO THERAPEUTICS, INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a  securities  class  action  lawsuit  has  been  filed  in  the  United States District Court for the Southern District of California against Sorrento Therapeutics, Inc. GlobeNewswire
06:20AM	CLASS ACTION UPDATE for SRNE, WFC and ENDP: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
12:20AM	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Sorrento Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - SRNE ACCESSWIRE
Jul-08-20 09:03PM	Can This Coronavirus Stock Soar 230%? 5-Star Analyst Thinks So TipRanks
06:46PM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Sorrento Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 27, 2020 - SRNE Newsfile
05:50PM	Sorrento Therapeutics (SRNE) Stock Sinks As Market Gains: What You Should Know Zacks
11:30AM	Has Sorrento Therapeutics (SRNE) Outpaced Other Medical Stocks This Year? Zacks
11:15AM	Will Sorrento Therapeutics' Shares March Higher, Can It Continue? Zacks
09:45AM	CLASS ACTION UPDATE for SRNE, CLNY and CCL: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
09:12AM	Sorrento Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Sorrento Therapeutics, Inc. To Contact The Firm Newsfile
Jul-07-20 02:43PM	SRNE ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of July 27, 2020 in the Class Action Filed on Behalf of Sorrento Therapeutics, Inc. Limited Shareholders Newsfile
01:15PM	SRNE Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Sorrento Therapeutics, Inc Shareholders of Class Action Against and Encourages Investors With Losses Exceeding $250K to Contact the Firm ACCESSWIRE
10:02AM	Better Coronavirus Stock: Moderna vs. Sorrento Therapeutics Motley Fool
Jul-06-20 08:19PM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Sorrento Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 27, 2020 - SRNE Newsfile

Sorrento Therapeutics, Inc., a clinical stage biopharma company, develops therapies for cancer, autoimmune, inflammatory, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutics by leveraging its proprietary G-MAB antibody library and targeted delivery modalities, which include chimeric antigen receptor T-cell therapy (CAR-T), dimeric antigen receptor T-cell therapy, and antibody drug conjugates, as well as bispecific antibody approaches. It also offers Sofusa, a drug delivery technology that delivers biologics directly into the lymphatic system. In addition, the company's clinical programs in development include anti-CD38 CAR-T therapy for the treatment of multiple myeloma, as well as for amyloidosis and graft-versus-host diseases. Further, it develops resiniferatoxin, a non-opioid-based TRPV1 agonist neurotoxin for late stage cancer and osteoarthritis knee pain treatment; and ZTlido, a lidocaine delivery system for the treatment of postherpetic neuralgia. Additionally, the company engages in the development of SEMDEXA, an injectable viscous gel formulation, which is Phase III trial for the treatment of sciatica, a pathology of low back pain; and SP-103, an investigational non-aqueous lidocaine topical system undergoing clinical development in chronic low back pain conditions. It has various collaborations with SmartPharm Therapeutics Inc. to develop gene-encoded antibody vaccine to protect against COVID-19; Celularity, Inc. for initiating Phase I/II clinical study, including up to 86 patients with COVID-19; and Mount Sinai Health System to develop COVI-SHIELD, an antibody therapy targeting SARS-CoV-2 infection, as well as a research testing agreement with The University of Texas Medical Branch at Galveston for the preclinical testing of Sorrento's COVID-19 therapeutic product candidates. The company was founded in 2006 and is based in San Diego, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Smith Robin L	Director	Mar 05	Buy	2.27	40,000	90,896	60,000	Mar 05 01:58 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience